Figure 1 | Scientific Reports

Figure 1

From: Comparison of circulating tumor cells and AR-V7 as clinical biomarker in metastatic castration-resistant prostate cancer patients

Figure 1

Patient subgrouping according to biomarker status. For comparative analysis of either CTC (A) or AR-V7 (B) as clinical biomarker, the overall cohort was stratified according to the respective biomarker status. Subsequently, subgroups were further subdivivded according to the respective other biomarker status. Colored boxes indicate identical subgroups.

Back to article page